Molbio Diagnostics Limited IPO
About Molbio Diagnostics Limited
Incorporated in October 2000, Molbio Diagnostics Limited is a global point-of-care (POC) molecular diagnostics company engaged in the research, development, manufacturing, and commercialization of rapid diagnostic solutions for infectious and non-communicable diseases. The company has developed its proprietary ‘Truenat’ platform, a portable and battery-operated PCR-based molecular diagnostics system designed to deliver accurate molecular test results within an hour, including in resource-limited and decentralized healthcare settings. Its solutions are aimed at enabling timely disease detection and expanding access to advanced molecular diagnostics across diverse healthcare environments.
IPO Details
81.59
₹768.00 - 807.00
18
₹14,526
IPO
BSE
INE869T01028
138 (17.1)
IPO Timeline
Subscription Details
3.85x
14.45x
42.52x
19.04x
Molbio Diagnostics Limited Lot Size
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 18 | ₹14,526 |
| Retail (Max) | 1 | 18 | ₹14,526 |
| HNI (Min) | 2 | 36 | ₹29,052 |
FAQs on Molbio Diagnostics Limited IPO
What are allotment date for the Molbio Diagnostics Limited ?
Allotment: 13-08-2026
What are the open and close dates for the Molbio Diagnostics Limited IPO ?
Opens on 10-08-2026, closes on 12-08-2026.
Can NRIs apply for the Molbio Diagnostics Limited IPO through PL Capital?
Yes, NRIs can apply for the Molbio Diagnostics Limited IPO through PL Capital, subject to RBI and SEBI guidelines. Applications can be made via the NRE or NRO account route.
Where is the Molbio Diagnostics Limited IPO getting listed?
The Molbio Diagnostics Limited IPO will be listed on BSE. The exact listing date is 17-08-2026.
What is the minimum and maximum investment allowed in the Molbio Diagnostics Limited IPO?
The minimum investment for retail investors in the Molbio Diagnostics Limited IPO is ₹14,526. The maximum retail investment allowed is ₹14,526.
What is the GMP for this IPO?
Current GMP is 138 (17.1%)
